PRKN and Parkinson disease: To further the relationship between PD-related mutations and increased TSPO expression, fibroblasts from PD patients (n = 4) bearing point mutations and/or exon deletions on the PARK2 gene (Table 1) were characterised by significant TSPO over-expression when compared to age-and-sex-matched controls.